EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers-Reference-Cited by-同舟云学术

EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers

Published:2018-04-06 Issue:4 Volume:10 Page:109
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Wilson Joanna,Manet Evelyne,Gruffat Henri,Busson Pierre,Blondel Marc^ORCID,Fahraeus Robin

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

http://www.mdpi.com/2072-6694/10/4/109/pdf

Reference221 articles.

1. Direct Evidence for the Presence of Epstein-Barr Virus DNA and Nuclear Antigen in Malignant Epithelial Cells from Patients with Poorly Differentiated Carcinoma of the Nasopharynx

2. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

3. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies

4. Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

5. Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathologic Insights and Molecular Oncogenesis: Understanding Epstein-Barr Virus-Induced B-cell Lymphoproliferations;International Journal of Surgical Pathology;2024-08-21

2. Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases;International Journal of Molecular Sciences;2024-07-26

3. Histone methylation in Epstein–Barr virus-associated diseases;Epigenomics;2024-05-10

4. Epstein-Barr virus BRRF1 induces butyrophilin 2A1 in nasopharyngeal carcinoma cells via the IL-22/JAK3-STAT3 pathway;2023-08-17

5. Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation;Biomedicine & Pharmacotherapy;2023-08